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Abstract
Background: For safe clinical application of engineered cartilage made from mesenchymal stem cells (MSCs),
molecular mechanisms for chondrogenic differentiation must be known in detail. Changes in gene expression and
extracellular matrix synthesis have been extensively studied, but the epigenomic modifications underlying these
changes have not been described. To this end we performed whole-genome chromatin immunoprecipitation and
deep sequencing to quantify six histone modifications, reduced representation bisulphite sequencing to quantify
DNA methylation and mRNA microarrays to quantify gene expression before and after 7 days of chondrogenic
differentiation of MSCs in an alginate scaffold. To add to the clinical relevance of our observations, the study is
based on primary bone marrow-derived MSCs from four donors, allowing us to investigate inter-individual
variations.
Results: We see two levels of relationship between epigenetic marking and gene expression. First, a large number
of genes ontogenetically linked to MSC properties and the musculoskeletal system are epigenetically prepatterned
by moderate changes in H3K4me3 and H3K9ac near transcription start sites. Most of these genes remain
transcriptionally unaltered. Second, transcriptionally upregulated genes, more closely associated with
chondrogenesis, are marked by H3K36me3 in gene bodies, highly increased H3K4me3 and H3K9ac on promoters
and 5' end of genes, and increased H3K27ac and H3K4me1 marking in at least one enhancer region per
upregulated gene. Within the 7-day time frame, changes in promoter DNA methylation do not correlate
significantly with changes in gene expression. Inter-donor variability analysis shows high level of similarity between
the donors for this data set.
Conclusions: Histone modifications, rather than DNA methylation, provide the primary epigenetic control of early
differentiation of MSCs towards the chondrogenic lineage.
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The best treatment of lesions of hyaline cartilage known
to date is transplantation of in vitro expanded autolo-
gous chondrocytes [1]. However, as articular chondrocytes
dedifferentiate during in vitro culture, the resulting tissue
frequently consists of a mixture of hyaline and fibrous car-
tilage. A better strategy may be to produce an implant of
hyaline cartilage by in vitro tissue engineering using mes-
enchymal stem cells (MSCs) and a biomaterial. Several
approaches including a variety of scaffold systems have
been used to induce chondrogenic differentiation of MSCs,
but so far all have failed to produce perfect hyaline cartil-
age for clinical use [1,2]. To achieve this, it is important to
understand the processes that regulate chondrogenic dif-
ferentiation of MSCs.
Changes in epigenetic marks are known to be important
regulatory factors in stem cell differentiation. Gene expres-
sion is correlated with the level of post-translational
modifications of histone tails and DNA methylation of pro-
moter regions. For embryonic stem cells (ESCs), lineage
commitment is associated with repression of genes import-
ant for differentiation along other lineages [3-5]. This
process frequently involves the polycomb-group mediated
trimethylation of lysine 27 of histone 3 (H3K27me3) and
DNA methylation of the promoter regions [6,7]. Transcrip-
tionally active genes are marked by monoubiquitination of
H2B followed by trimethylation of H3K4 (H3K4me3) and
H3K9 acetylation (H3K9ac) on nucleosomes close to the
transcription start site (TSS). Other histone modifications,
including H3K36me3, are associated with transcriptional
elongation and occur throughout the body of transcribed
genes. Additional transcriptional control is provided by
cis-acting regulatory regions marked by H3K4me1 and
H3K27ac [4,5,8,9].
Less is known about the epigenetic control of gene ex-
pression during differentiation of multipotent stem cells.
Analysis of genes regulating adipogenic differentiation of
human MSCs revealed dynamic changes in histone
marks reminiscent of those seen in ESCs [10] and mod-
est changes in promoter DNA methylation [11]. Recent
studies of differentiation of murine myogenic precursor
lines and in vivo differentiation of murine hair follicle
stem cells have focused on the importance of H3K27me3
[12,13]. Likewise, studies of human hematopoietic stem
cells have focused on changes in genes concomitantly
marked by H3K4me3 and H3K27me3 and changes in
DNA methylation [6,14-16]. Except for a few studies of
the DNA methylation status of some genes involved dur-
ing in vitro chondrogenesis [17-19], nothing is known to
date about epigenetic changes during chondrogenic differ-
entiation of MSCs.
Embryological chondrogenesis is controlled by a com-
plex interplay of growth- and transcription factors.
Among the essential secreted factors are Tgfβ and Bmp
proteins [20]. For in vitro differentiation of human
MSCs a combination of TGFβ and BMP2 yields the
most hyaline-like cartilage [21]. In vivo, the Sox9 tran-
scription factor (TF) is essential through the entire
process of chondrogenesis [22] but the co-activators L-
Sox5 and Sox6 are also important for cartilage formation
[23,24]. In vitro, transfection of SOX9, 5 and 6 together
is sufficient to induce permanent cartilage in mesen-
chymal precursors [25]. Using TGFβ1 and BMP2 to
induce chondrogenic differentiation in hMSCs in a self-
gelling alginate scaffold system, we have recently shown
that the differentiated cells upregulate the extracellular
matrix (ECM) molecules typical of hyaline cartilage, and
downregulate molecules typical of MSC functionality
[26]. Inthissystem,theSOXTFsareupregulatedsufficiently
to allow transcription of all essential ECM molecules. We
reasoned that a system where availability of TFs is not rate
limiting should be suitable to study the relationship between
changes in gene expression and concomitant epigenetic
changes. To this end we used whole-genome chromatin
immunoprecipitation and deep sequencing (ChIP-seq) to
quantify H3K4me3, H3K9ac, H327me3, H3K36me3,
H3K4me1 and H3K27ac, and reduced representation
bisulphite sequencing (RRBS) to quantify DNA methyla-
tion in hMSCs before and after 7 days of chondrogenic dif-
ferentiation. To add to the clinical relevance of our
observations, the study is based on primary bone marrow-
derived MSCs (BM-MSC) from four donors, which
allowed us to also investigate the inter-individual variations
in the dynamics of epigenetic marks. We find evidence of
two levels of relationship between epigenetic marking and
gene expression during chondrogenic differentiation of
MSCs: a prepatterning level marked by moderate changes
in H3K4me3 and H3K9ac near TSSs and no or little
change in gene expression, and a level associated with tran-
scriptional upregulation marked by increased H3K36me3
along the gene body and highly increased H3K4me3 and
H3K9ac. The first level is generally associated with the
musculoskeletal system and MSC functionality, while the
second level is more specifically associated with
chondrogenesis. Within the 7-day time frame, changes in
promoter DNA methylation do not correlate significantly
with changes in gene expression.
Results
Chondrogenic differentiation of hBM-MSCs in 3D scaffold
In order to create an implant which resembles articular
cartilage of the knee, we embedded MSCs in alginate discs
with the thickness of knee cartilage and exposed these
constructs to a differentiation cocktail containing TGFB1,
BMP2 and dexamethasone [26]. Evidence of chondrogenic
differentiation is shown by upregulation of the chon-
drocyte marker gene COL2A1 and downregulation of
the MSC marker gene CXCL12 (Figure 1A), by the
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http://www.biomedcentral.com/1471-2164/14/105Figure 1 Chondrogenic differentiation of hBM-MSCs in 3D scaffold. (A) Levels of gene expression over 3 weeks of chondrogenic
differentiation for chondrogenic and MSC signature genes and control genes measured by microarray analysis. Shown are mean values for
donors 2–4. Error bars are standard deviations (SD). (B) Immunofluorescence histochemical stainings for SOX9 and type II collagen (left) and
aggrecan (right) after three weeks of chondrogenic differentiation in one representative donor (Donor 2). (C) Secretion of sulfated
glycosaminoglycans (sGAG) during three weeks of culture in alginate discs in either normal culture medium (No diff) or in the chondrogenic
differentiation medium. Data presented are mean values of technical quadruplicates for each of the four donors. Error bars show standard
deviations of the technical replicates. (D) Microarray expression analysis of chondrogenic and mesenchymal signature genes and unchanged
control genes. Log2 transformed mean values for change in expression between day 0 and day 7 of chondrogenic differentiation are shown
relative to GAPDH expression. Shown are mean values of the results for the four donors (mean of biological quadruplicates). Error bars are SD.
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http://www.biomedcentral.com/1471-2164/14/105distribution of type II collagen and aggrecan throughout
the extracellular space and SOX9 in the nuclei at three
weeks of differentiation (Figure 1B), and by the increased
synthesis of glycosaminoglycans (GAGs) during the differ-
entiation period (Figure 1C). Details of gene expression
and ECM composition using this model system are
described in [26].
To first focus our epigenetic analyses on one set of genes
typical of differentiated chondrocytes and another set typ-
ical of undifferentiated MSCs, we chose 10 canonical
chondrogenic (COL2A1, COL9A2, COL9A3, COL11A1,
COL11A2, ACAN, COMP, SOX5, SOX6 and SOX9) and
mesenchymal (CXCL12, IL6, VCAM1, CCL2, PLAU,
CLCF1, ADAMTS1, EFEMP1, ACTA2 and TPM1) signa-
ture genes (Figure 1D). The chondrogenic signature genes
were selected because collagens II, IX and XI are the
molecules required for synthesis of the hyaline cartilage
collagen heterofibrils, which make up approximately 40%
of the dry weight of hyaline cartilage. Aggrecan and COMP
are two other essential components of hyaline ECM, while
SOX9, 6 and 5 are essential transcription factors. The
MSC signature genes were selected because they encode
chemokines, cytokines and ECM degradation molecules
important for the role played by MSCs in inflammation
(CXCL12, IL6,VCAM1, CCL2, PLAU, CLCF1, ADAMTS1),
or represent molecules involved in differentiation along
other lineages (ACTA2, TPM1). All these genes are widely
distributed throughout the genome, suggesting that if
genes respond similarly to the differentiation process, this
impact occurs genome-wide. We also included ten control
genes representing highly (NUCB1, RPL3 and HSP90B1)
and moderately (E2F4, TBP, SDHA) expressed housekeep-
ing genes as well as non-expressed endodermal (GATA5,
PDX1) and ectodermal (SOX2, GFAP) genes. The change
in mRNA levels for these genes between day 0 and day 7 is
shown in Figure 1D, and shows upregulation of the
chondrogenic signature genes, downregulation of the MSC
signature genes and no change for the control genes. Lists
of all up- and downregulated genes in this differentiation
system are found in Additional file 1 and Additional file 2.
Histone modifications in promoters and gene bodies
To describe the relationship between changes in gene
expression and changes observed in the histone tails in
nucleosomes, we quantified the presence of the tran-
scriptionally permissive marks H3K4me3 and H3K9ac
and the repressive mark H3K27me3 around the respect-
ive TSS in BM-MSCs from all four donors before and
after 7 days of chondrogenic differentiation. We also
quantified H3K36me3 throughout the length of the gene
body. The genome-wide inter-donor variability of enrich-
ment for the different histone marks during the differenti-
ation period is presented in Figure 2A, and shows a
remarkable similarity between donors for H3K4me3 (R ≥
0.95), H3K9ac (R ≥ 0.85) and H3K36me3 (R ≥ 0.82). We
found greater between-donor variability for H3K27me3
around the TSS, but this likely reflects the relatively low
enrichment levels for this mark.
To extend the comparison to include both increases
and decreases in histone marks, and to relate these
changes to changes in gene expression, heat maps of
genome-wide changes in facilitating promoter marks
H3K4me3 and H3K9ac and restrictive promoter mark
H4K27me3 are shown in Figure 2B, and a heat map of
changes in H3K36me3 is shown in Figure 2C, in both
cases directly comparable to changes in gene expression.
As expected the maps representing the different pro-
moter marks cluster together, with no apparent order
between the donors. Upregulated H3K4me3 marks are
seen to be closely related to promoters of genes with
increased expression, while upregulated H3K9ac marks
genes with increased expression, but also unchanged and
perhaps even some downregulated genes. Upregulated
H3K27me3 clusters with downregulated genes (Figure 2B).
For H3K36me3 the relationship between enhanced his-
tone mark and increased gene expression seems even
stronger (Figure 2C).
Next we examined changes in histone modifications near
upregulated chondrogenic signature genes, downregulated
MSC genes and unchanged control genes. COL2A1 and
CXCL12 are shown as representatives for the signature
gene clusters (Figure 3). In MSCs, the promoter region of
COL2A1 is marked by wide enrichment in H3K27me3 and
no H3K4me3, which just shows a small peak in the first in-
tron. This inactive state changed to a state marked by
elevated H3K4me3 around the TSS. Interestingly, we did
not observe a complete disappearance of H3K27me3.
While this is reminiscent of the bivalent, or poised state
described for non-transcribed, developmentally important
genes in ESCs [4,5,8], we note that at this time there was
already a high level of transcription of the COL2A1 gene
(Figure 1B). Thus, this apparent overlap is more likely to
reflect that not all cells in the population express COL2A1
at this stage of differentiation. Promoter enrichment in
H3K9ac and gene body occupancy by H3K36me3 are con-
sistent with ongoing transcription (Figure 3A). In contrast,
for the downregulated MSC marker gene CXCL12 we note
the disappearance of H3K9ac and H3K36me3 and a re-
striction in H3K4me3 occupancy to the vicinity of the TSS.
H3K27me3 increases significantly around the TSS but
remains low at day 7 (Figure 3B). The persistently non-
transcribed gene PDX1 shows no activity marks and high
levels of H3K27me3 throughout the gene and extending
on both sides (Additional file 3A). As expected, the highly
expressed housekeeping gene HSP90B1 displays high levels
of the activity marks H3K4me3, H3K9ac and H3K36me3
and no H3K27me3 (Additional file 3B). Analysis of the set
of chondrogenic signature genes reveals a >2-fold increase
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H3K36me3 in all of the genes (Figure 4A). H3K27me3
shows a >2-fold decrease during differentiation for four of
the chondrogenic signature genes. All the downregulated
MSC genes show reduced H3K4me3, H3K36me3 and
H3K9ac on day 7 of differentiation, while the genes are still
being expressed at moderate levels. Most of these genes
also show a minor increase in H3K27me3 (Figure 4B).
Control genes do not show any significant changes in any
of the investigated marks (Figure 4C). Thus, for practically
all signature genes examined, there is a close association
between gene expression and detection of marks of active
genes, and an inverse relationship between mRNA level
and H3K27me3.
Genome wide correlation between changes in H3K4me3
and changes in gene expression
Based on the association observed between increased
H3K4me3 and increased expression for the chondrogenic
signature genes, we next investigated if increased
H3K4me3 could be found for all genes that were tran-
scriptionally upregulated. Of the 488 genes with increased
mRNA levels, 90% were associated with increased
H3K4me3 around the TSS, with approximately 65%
showing a >2-fold increase (data not shown). We next
determined if changes in H3K4me3 were restricted to
genes with concomitant changes in mRNA levels. While
approximately 1000 genes were significantly either up- or
downregulated upon chondrogenic differentiation, >2600
genes showed significant changes in H3K4me3 near the
TSS (Additional file 4A). Gene ontology (GO)-term ana-
lysis of genes with increased H3K4me3 showed enrich-
ment of functions linked to skeletal system development,
ECM and chondrocyte differentiation. The functional
terms for the genes with decreasing H3K4me3 were
more general and associated with regulation of cytoskel-
eton, apoptosis, cell development or metabolic processes
(Additional file 4B). Genome-wide, only 25% of the genes
associated with a >2-fold change in H3K4me3 showed
significant change in expression on day 7 (p<0.05)
(Additional file 5A). Hardly any of these genes would
change in expression over the next two weeks of differ-
entiation, as the vast majority of genes that show
change in expression during the first three weeks do so
during the first week in this differentiation system.
These results indicate that H3K4me3 enrichment occurs
during chondrogenic differentiation on genes that are onto-
logically close to cartilage and musculoskeletal systems, but
that these genes are not transcriptionally activated at the
≥2-fold level defined as significant in this study.
To determine if the magnitude of change in H3K4me3
might be a predictor for a change in gene expression we
looked at the 500 regions with the greatest increase or
decrease in H3K4me3 (Figure 5A). We found that 41%
of the genes with the greatest increase, and 42% of the
genes with the greatest decrease in H3K4me3 showed
>2-fold transcriptional up- or downregulation, respect-
ively (Additional file 4C), compared with 25% for all
genes with changes in H3K4me3. GO-term analysis of
the upregulated genes showed a closer correlation to
ECM and cartilage (Figure 5B), while the downregulated
genes showed properties associated with MSCs: differen-
tiation to other lineages and association with angiogen-
esis and inflammation (Figure 5B). If the selection was
limited further to include only the 100 TSS regions with
the greatest level of up- or downregulation in H3K4me3,
65% of the associated genes were found to be differen-
tially expressed (data not shown). Of the genes associated
with the greatest upregulation of H3K4me3, but with <2-
fold increase in mRNA level, many were either signifi-
cantly upregulated (p<0.05) but <2-fold increased, were
upregulated at a later time point during differentiation
[26], showed activation of alternative promoters or were
wrongly annotated (Additional file 6). In fact, only 8 of the
100 genes with the highest increase in H3K4me3 were
transcriptionally unaffected. A similar conclusion could be
drawn from the analysis of the genes that were most
reduced in H3K4me3. Thus, the greatest changes in
H3K4me3 were almost always associated with a change in
gene expression.
Correlation between combination of histone
modifications and gene expression
Most of the genes that were transcriptionally unchanged
but with highly increased H3K4me3 had no increase in
either H3K9ac or H3K36me3 or both. This suggests that
lack of H3K9ac and/or H3K36me3 occupancy could ex-
plain why transcription of these genes did not change
(See figure on previous page.)
Figure 2 (A) Correlation between all combinations of pairs of donors for enriched histone marks. Each dot plot is a comparison between
the level of enrichment in a given histone mark after 7 days of differentiation from two donors. The values in each plot are the number of reads
observed in genome-wide 500 bp regions with enrichment of the histone mark in that particular region in cells from at least one of the two
donors. Included within each dot plot is the Spearman's rho correlation coefficient. Results for H3K27ac for donor 1 are not available due to a
failed experiment. (B) Heat-maps of changes in the course of 7 days of chondrogenic differentiation in promoter marks H3K27me3, H3K4me3 and
H3K9ac. Rows represent 500 bp regions where at least one experiment produced at least 200 aligned reads. The columns show changes in the
indicated histone modifications and are sorted using hierarchical clustering with the clusters represented at the top of the figure. The rows are
sorted using Principal Component Analysis where the order of the rows is defined by the first two principal components. Colour bars at the
bottom of the figure show the colour analogue to the log2 fold change in histone marking or gene expression. Each column has 96013 rows.
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http://www.biomedcentral.com/1471-2164/14/105despite their increased H3K4me3, or that changes in
H3K9ac and H3K36me3 did not occur because tran-
scription did not change despite changes in H3K4me3
marking. Based on this observation, we determined the
relationship between increased gene expression and the
presence of all the gene-associated histone modifications,
alone or in combination (Additional file 5). Not surpris-
ingly, H3K4me3 and H3K9ac were co-regulated around a
large number of genes. However, the histone mark that
most closely correlated with increased gene expression
was H3K36me3. Of the 488 genes with increased mRNA
levels, 94% had the H3K36me3 modification, 85% of these
were numerically increased from day 0 to day 7 of differ-
entiation, while 26% were >2-fold increased (Additional
file 5 and data not shown). Taken together, this shows that
highly increased levels of H3K4me3 and H3K9ac and
(See figure on previous page.)
Figure 3 Histone modification tracks of individual signature genes. (A) ChIP-seq signal tracks for histone modifications in a 100 kb window
around the TSS of chondrogenic marker gene COL2A1. Exon-intron structures and coding strand direction are depicted on top. UCSC Genome
Browser on Human Feb. 2009 (GRCh37/hg19) assembly. (B) ChIP-seq signal tracks for histone modifications in a 100 kb window around the TSS
of MSC marker gene CXCL12. (C) ChIP-seq signal tracks for H3K27me3 in a higher resolution of MSC marker gene CXCL12.
Figure 4 Profiling of epigenetic changes near signature genes. (A) Changes in histone marks for chondrogenic signature genes between
day 0 and day 7 of chondrogenic differentiation. For H3K4me3, H3K27me3 and H3K9ac a 4 kb window around the TSS of all known transcripts
was compared between the differentiation stages, while K36me3 reads were counted over the whole length of the longest known transcript.
Shown is the log2 transformed histone enrichment ratio between differentiated cells and MSCs. Mean values of the results from the four donors
(biological replicates) are shown. Error bars are SD. (B) Changes in histone marks for MSC signature genes between day 0 and day 7 of
chondrogenic differentiation. Mean values of four donors with SD. (C) Changes in histone marks for unchanged control genes between day 0
and day 7 of chondrogenic differentiation. Mean values of four donors with SD.
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http://www.biomedcentral.com/1471-2164/14/105upregulated levels of H3K36me3 are found near practic-
ally every transcriptionally upregulated gene in this differ-
entiation system.
The impact of cis-acting regulatory elements
Regulation of gene transcription is controlled by factors
acting in promoter regions as well as distant cis-regulatory
elements. Different histone marks have been described to
correlate with promoter and enhancer regions. Active
enhancers are known to be marked by H3K4me1 and
H3K27ac [27,28]. Heat maps for the associations between
genes with changes in expression and H3K4me1 and
H3K27ac marking within 50 kb of the TSS of these genes
is shown in Figure 6A. A very clear association is seen be-
tween up- or down-regulation in gene expression and
corresponding up- or down-regulation of the histone
marks. Genome-wide, more than 70% of the upregulated
genes were in the vicinity of upregulated enhancer regions,
but since the number of regions with increased H3K4me1
or H3K27ac was high, only approximately 15% of the genes
within 50 kb of changes in these marks showed changes in
mRNA expression (Additional file 7). This suggests that
enhancer regions are important for most upregulated
genes, but that the predictive power of a change in regula-
tory regions for the transcription of nearby genes is limited.
A genome-wide list of genes which change in expression
and show increase or decrease in one of these two regula-
tory marks in a 50 kb area is given as Additional file 8
(H3K4me1) and Additional file 9 (H3K27ac).
In order to identify potential chondrogenic enhancer
regions, we investigated changes in these regulatory
marks within 50 kb of the TSS of genes that changed
transcriptionally during chondrogenic differentiation.
For our signature genes, we found at least one site of >2
fold enrichment in both histone modifications near every
chondrogenic signature gene, and at least one site with a
significant >2 fold decrease of these marks near every
MSC signature gene (Figure 6B). None of the unchanged
control genes showed changes in H3K4me1 or H3K27ac
(data not shown). The changes in H3K4me1 and
H3K27ac near the chondrogenic marker gene COL2A1
are shown in Figure 6C. We detected six areas with en-
richment in both H3K4me1 and H3K27ac in the
chondrogenically differentiated cells. Two of these could
be identified as described and validated enhancer regions
with binding sites for SOX9 [30-33]. The other four
regions (Figure 6C, marked in red) have not yet been
described, and are likely to be new regulatory elements
of importance for the regulation of COL2A1 expression.
Transcription factor binding sites in cis-acting regulatory
regions - Motif search
The impact of changes in cis-acting regulatory elements
on the regulation of gene expression most likely occurs
through the binding of TFs. In order to identify TFs
which may be involved in the regulation of chondrogenesis
we performed a motif search in all areas with increase of
H3K27ac during the differentiation process, using JASPAR,
Transfac and Uniprobe databases. We found enrichment
in motifs which could bind TFs belonging to several fam-
ilies (Figure 6D). The SRY family is especially important in
the context of chondrogenesis, as it contains SOX5, 6 and
9, which are essential and sufficient to start the differenti-
ation process [23,34]. The literature also contains evidence
of involvement in chondrogenesis of members of all the
other families with enriched binding motifs in these
regions [35-38]. Interestingly, for most of these TF families
binding motifs could be found also within the new regula-
tory areas close to the COL2A1 gene, further supporting
their potential role in chondrogenic differentiation of
MSCs (Figure 6D). Most significantly, new regions 1, 2 and
4 could be shown to contain 3, 8 and 2 sequences identical
to the SOX9 binding motif (AACAAT), respectively, while
new region 3 contains no such sequences.
Donor variability
While the data comparing histone modifications genome-
wide between all four donors shows a low level of overall
donor variability (Figure 2), some individual genes show
variation between donors in mRNA levels and associated
histone modifications. One example is COL2A1, where
the gene expression on day 7 for donor 1 was considerably
lower than for the other three donors. A similar observa-
tion was made for the upregulated gene SOX8,b u tn o tf o r
SOX9 (Figure 7A). When changes in histone modifications
were examined for these genes, a much lower rate of
change was observed for donor 1 for H3K4me3, K36me3
and H3K9ac for COL2A1 and SOX8, but not for SOX9
(Figure 7B and 7C), suggesting a correlation between gene
expression and histone modification also at the single
gene and individual donor level. Of the other genes identi-
fied which showed delayed transcriptional increase in
(See figure on previous page.)
Figure 5 Correlation between changes in gene expression and changes in promoter mark H3K4me3. (A) Association between change in
gene expression and change in H3K4me3 among the 500 regions which showed the highest increase or decrease in H3K4me3 in promoter
regions. (B) GO term analysis of genes within the top 500 H3K4me3 clusters which reached >2-fold expression change at day 7 of chondrogenic
differentiation. DAVID cluster analysis was performed and one typical term per cluster is shown.
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http://www.biomedcentral.com/1471-2164/14/105Figure 6 Finding potential cis-regulatory elements. (A) Heat maps of H3K4me1 and H3K27ac marks in regions located within 50 kb of the 5
0
end of genes with significant changes in expression in the course of 7 days of chondrogenic differentiation in donors 2–4. Data for donor 1 are
not available due to a failed experiment. Definition of rows, sorting of rows and clustering of columns as described in the Legend to Figure 2B.
Each column has 262 533 rows. (B) Profiles of the regulatory histone modification marks for selected chondrogenic and mesenchymal signature
genes. Shown is the 500 bp bin with the highest histone enrichment ratio for the indicated genes in a 50 kb area as mean value of three donors.
Error bars are SD. (C) ChIP-seq signal tracks for H3K4me1 and H3K27ac in a 50 kb area on either side of the TSS of the COL2A1 gene. Validated
(green) and potential new [29] regulatory areas are highlighted. (D) Left side: Motif scanning for transcription factor binding sites in regions
enriched for H3K27ac in differentiated cells. Example motif shown from Jaspar database. The members of the TF families are TFs known to be
involved in chondrogenesis which share similar binding motifs. Right side: Motif hits in regulatory areas around the COL2A1 gene.
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to have decreased upregulation of H3K4me3, K36me3
and H3K9ac for donor 1 compared with donors 2–4.
Interestingly, there were no clear differences in these his-
tone marks, H3K27me3 or DNA methylation at COL2A1
or SOX8 in the undifferentiated cells, which suggests that
these marks are not sufficient to predict the delayed differ-
entiation response of donor 1.
DNA methylation
To determine if there is a relationship between DNA
methylation and changes in gene expression before and
after 7 days of chondrogenic differentiation, genome-
wide DNA methylation in CpG-rich regions was mapped
using RRBS. More than 2 × 10
6 unique CpGs were
observed with at least 10X coverage in most samples.
The overall methylation patterns were highly similar
Figure 7 Donor variability for single genes. (A) Gene expression analysis by real-time RT-qPCR. COL2A1, SOX8 and SOX9 are shown relative to
GAPDH expression for the individual donors. Note log10 scale. Each sample was measured in triplicate. Mean values shown, error bars reflect the
Standard deviation. (B) Changes in histone modifications for individual donors. For H3K4me3, H3K27me3 and H3K9ac the sum of aligned reads
within a 4 kb window around the TSS of all Ensembl transcripts of indicated genes is shown in both differentiation stages, while for H3K36me3
the sum of the reads for the longest transcript for each ensembl gene is given. (C) ChIP-seq signal tracks for donor 1 and 2 showing the
indicated histone modifications in a 60 kb window around the TSS of indicated genes.
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in CpG-rich regions (including CpG islands) tended to
be hypomethylated (<10% median methylation across
covered CpGs) while CpGs in CpG-poor regions tended
to be hypermethylated (>50% median methylation;
Additional file 10A). This relationship was preserved
when the promoter regions were examined specifically.
A highly significant correlation was found between the
average methylation values for the MSC and the aver-
age methylation values for the chondrocytes in pro-
moter regions (r
2 = 0.78), with the methylation states of
the vast majority of promoters remaining unchanged
[11]. For the MSC and chondrocyte signature genes,
promoters were hypomethylated both before and after
chondrogenesis, which suggests that DNA methylation
is unlikely to play a major role in regulating these key
genes during chondrogenesis. Genome-wide, only 37
promoters (0.14% of those examined), including those
of 9 microRNAs, showed a mean increase of at least
50% in methylation across the donors, and only 284
(1.1%) showed more than a 25% increase. However,
except for GAS6 (growth-arrest specific 6, five-fold
downregulated, increased promoter methylation), these
genes were generally expressed at low levels both be-
fore and after differentiation and no correlation to
changes in the investigated histone marks could be
detected. Moreover, at least 15 of the 37 genes that
gained >50% methylation across the donors were
already hypermethylated in one of the donors prior to
differentiation, which suggests that the observed pro-
moter methylation events are not likely to be directly
linked to regulation of chondrogenesis.
Discussion
Chondrogenic differentiation opens up a new epigenetic
landscape in MSCs
In vitro tissue engineering of hyaline cartilage implants
using MSCs and a biomaterial may well represent the
best future treatment option for patients with lesions of
articular cartilage. To be applicable to a wide range of
patients the tissue engineering strategy should be robust,
with little between-donor variability. Preferably, the
differentiation process should be induced synchronously
in all the cells used. A priori, this may be difficult to
achieve: MSCs from different donors behave differently
in cell expansion and differentiation cultures, and MSCs
are known to be heterogenous both phenotypically and
functionally [39,40]. In contrast, using the alginate disc
differentiation procedure described here, hyaline ECM
molecules are produced by the vast majority of cells in all
donors tested so far [26] (Küchler AM and Brinchmann
JE, unpublished results). However, there is a delay between
upregulation of mRNA and detection of ECM molecules,
and ECM molecule synthesis does not seem to be
synchronous. Against this background, we observe a re-
markable similarity between the histone modifications
induced after seven days of chondrogenic differentiation
using bone marrow-derived MSCs from four donors. At
this time, a new epigenetic landscape is opened up in
these cells. Changes in the H3K4me3 and H3K9ac
modifications occur near the TSS in thousands of genes,
many of which are ontogenetically linked to skeletal sys-
tem development, ECM, chondrocyte differentiation and
MSC functionality. Although these modifications are
known to be associated with initiation of transcription
[4,41], no significant change in mRNA levels is actually
observed in the majority of these genes. With the level of
change in gene expression set as significant in this study
(≥2-fold) it is possible that a small change in gene expres-
sion may accompany these changes in histone marks, or
perhaps a greater change in a very small subset of cells.
However, these changes are most reminiscent of the
prepatterning of developmental gene expression by
H3K4me3 recently observed in zebrafish before zygotic
genome activation [42]. It is possible that every
chondrogenic differentiation protocol would induce an
epigenetic state that maintains activation potential of
genes required both for the desired and also for related
differentiation pathways [15]. It is also possible that cer-
tain components of the present differentiation cocktail, e.
g. BMP2, may improve chondrogenic differentiation
(Jakobsen RB, Østrup E, Mikkelsen TS and Brinchmann
JE, unpublished observations) while at the same time set-
ting an epigenetic stage also for bone differentiation.
Close correlation between histone marks and gene
expression
Although many genes within the general domain of the
musculoskeletal system show increased H3K4me3 fol-
lowing 7 days of chondrogenic differentiation, only the
genes with the highest increase in H3K4me3 could be
correlated with increased gene expression. The distribu-
tion of H3K4me3 and H3K9ac was, in many instances,
very similar, suggesting co-occurrence on the same his-
tone tails. H3K4me3 and H3K9ac may poise genes for
transcription without transcription actually occurring.
However, increased H3K4me3 and H3K9ac in promoter
regions is, on its own, unlikely to explain the close
correlation between highly increased H3K4me3 and
H3K9ac and increased transcriptional activity. Increase
in the distribution of these modifications within the gene
body may conceivably explain the increased rate of
transcription, as H3K4me3 has also been suggested to
stimulate transcriptional elongation [43]. However, the
modification most closely correlated with increased tran-
scription is H3K36me3. The combination of H3K4me3
with H3K36me3 is observed at practically every gene
with increased mRNA level, and at few other genes. The
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knowledge about the relationship between histone modi-
fications and transcription. Trimethylation of H3K4 is
regulated by several factors, including trithorax group
proteins and cyclin-dependent kinase-9 (CDK9) of the
positive transcription elongation factor-b complex (P-
TEFb) [43,44]. The regulation of H3K9ac is not well
known, but its co-occurrence with H3K4me3 has been
described [7,45], and the two modifications may have
common chromatin readers [46,47]. These modifications
frequently co-occur with RNA polymerase II [45]. How-
ever, transcriptional elongation does not occur in the ab-
sence of trimethylated H3K36 along the gene body.
Methylation of H3K36 is performed by the methy-
ltransferase Set2 and is, like H3K4 trimethylation,
dependent on CDK9 [44,48]. CDK9 and Set2 are part of
a large complex of proteins which is involved in the re-
lease of paused polymerase II [41]. With the factors re-
sponsible for trimethylation of H3K36 being part of the
transcription elongation complex, it is uncertain at this
time whether H3K36me3 is a prerequisite for, or a con-
sequence of the passage of this complex along the gene
body. In either case transcriptional elongation, heralded
by H3K36me3, is the most specific correlate of actively
transcribed genes in the present data set. Further re-
search will, hopefully, explain how transcriptional elong-
ation is restricted to a set of genes with particular
relevance for hyaline chondrogenesis in this differenti-
ation model.
Apparent co-occurrence of active and repressive marks
Genes regulated both by H3K4me3 and H3K27me3 in
the promoter region are called bivalent genes. ESCs are
known to have a high proportion of bivalent genes,
particularly genes responsible for specification along
lineages [4,5,8]. These genes are not transcribed as long
as differentiation is inhibited. On a cell population basis,
we also observed what looks like bivalent genes, both
among the upregulated chondrogenic signature genes
and among the downregulated MSC signature genes. On
day 7 of differentiation, transcription of all these genes
was observed. We cannot rule out the possibility that
there are genes among these that are actively transcribed
in the presence of both H3K4me3 and H3K27me3 near
the TSS. More likely, however, is an explanation based
on non-synchronous changes in histone modifications
and gene transcription between the different cells in a
heterogeneous population. This would imply, for COL2A1,
for instance, that one subset of MSCs lose H3K27me3 and
gain H3K4me3 (and H3K36me3) at day 7. This subset is
responsible for the observed increased level of COL2A1
mRNA, while another subset with retained H3K27me3
near the COL2A1 promoter does not support transcription.
The level of COL2A1 mRNA increases further through
days 14 and 21, which is consistent with subsequent loss of
H3K27me3 and gain of active marks in cells that are still
repressed at day 7.
Relationship between distal cis-regulatory elements and
gene expression
The genome-wide analysis of all 50 kb areas around TSS
revealed a correlation between gene expression and
changes in the regulatory histone marks H3K4me1 or
H3K27ac. For the signature genes, every upregulated
chondrogenic gene is associated with at least one
upregulated enhancer region and every downregulated
MSC-specific gene is associated with at least one
downregulated enhancer region, whereas none of the
control genes show any such change within the 50 kb
region. For the COL2A1 marker gene, 4 new cis-
regulatory regions were discovered, all containing bind-
ing motifs for TFs essential for chondrogenesis. This
strongly suggests that distal cis-regulatory regions im-
pact importantly on the regulation of gene expression in
this differentiation model. However, most of the histone
modifications marking cis-regulatory regions occurred
>50 kb away from genes with changed expression,
suggesting that the enhancers may be far removed from
the target gene.
Conclusion
We have performed genome-wide quantitative epigen-
etic analysis on biological replicates of primary human
MSCs undergoing chondrogenic differentiation in algin-
ate disc scaffolds relevant for tissue engineering of hya-
line cartilage. The differentiation cocktail and 3D culture
induce changes in H3K4me3 and H3K9ac in genes
associated with the musculoskeletal system, but mostly
in the absence of changes in gene expression. Increased
gene expression may be predicted by particularly high
increase in H3K4me3 and by increase in H3K36me3.
This implicates transcriptional elongation as the specifi-
city conferring, rate limiting step in the differentiation
process. Cis-regulatory activity marked by increasing
H3K27ac and H3K4me1 is involved in transcriptional
regulation in the vast majority of genes with altered ex-
pression. Within the 7-day time frame, changes in pro-
moter DNA methylation do not correlate significantly
with changes in gene expression.
Methods
Culture and validation of MSCs
The study was approved by the Regional Committee for
Medical Research Ethics, Southern Norway. Bone mar-
row was obtained from four healthy voluntary donors
following informed, written consent. The MSCs were
isolated and cultured as described in [26]. The cells were
validated as MSCs by expression of CD105, CD73, CD90
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CD45, CD14 and CD19. The multipotency of the MSCs
was validated by differentiation to osteogenic and
adipogenic lineages as previously described in [26].
In vitro chondrogenic differentiation
The chondrogenic differentiation system was described
previously [26]. Briefly, MSCs were established in a self-
gelling system containing PRONOVA-LVG alginate and
calcium-alginate-particles to a final alginate concentra-
tion of 1% and a final cell concentration of 5 × 10
6
cells/ml. Chondrogenic differentiation was induced by
500 ng/ml BMP2, 10 ng/ml TGFB1 and 0.1 μM dexa-
methasone in serum free medium containing supplements
as described [26].
Validation of extracellular matrix synthesis
Fluorescence immunohistochemistry was performed as
described [26] with reagents as specified in Additional
file 11. The supernatants from disc cultures were
analyzed for sulfated glycosaminoglycan content in tech-
nical quadruplicates for each donor using the Blyscan
™
kit (Biocolor Ltd).
RNA preparation and expression analysis
Total RNA was prepared using TRIzol (Invitrogen). De-
polymerisation of the alginate discs to obtain single cells
for RNA isolation was performed by enzymatic digestion
u s i n gG - L y a s e( k i n d l yp r o v i d e db yp r o f e s s o rG u d m u n d
Skjåk-Bræk) as described in [26]. RT-qPCR was performed
using TaqMan arrays (Applied Biosystems) and normalized
to GAPDH expression. Results are presented as mean plus
standard deviation of technical triplicates. Microarray
assays were performed in uniplicates per donor and
differentiation state using the Human-6 v3 Expression
Beadchips (Illumina), and the analysis was performed using
J-express 2009 [49].
ChIP-seq
After degelling, cells were fixed in 1% formaldehyd for
10 min at 37°C and stored at −80°C. ChIP and Illumina
sequencing library construction was performed as
described in [3,4].
Sequence analysis
Tracks were uploaded in a UCSC Genome Browser,
using unique reads extended to 200 bp. Experiments
were normalized by enforcing equal read counts. 500 bp
bins were generated, and the coverage in each bin was
calculated for both chip and control. For each bin, a fold
change value and a poisson p-value was generated. P-
values were FDR corrected. The read counts from all
experiments were quantile normalized. Bins with a log2
fold change >0.2 or <−0.2 in at least three of the four
replicates were defined as having an increased or
decreased signal, respectively. For quantification of
H3K27me3, H3K4me3, and H3K9ac the sum of aligned
reads within 2 kb on both sides of the TSS for each gene
was calculated. This was performed for all biological
replicates for both MSCs and differentiated cells, and a
mean for each cell population was calculated. For
H3K36me3, with known functionality throughout the
entire gene [50], the longest transcript for each Ensembl
gene was selected. The total number of aligned reads
within this transcript was then calculated for all bio-
logical replicates in both cell populations, and a mean
for each population was calculated. For the profiling of
H3K4me1 and H3K27ac signals the highest ratio of bins
associated to a single gene was calculated.
Gene association
For promoter marks, Ensembl transcripts were used to
identify transcripts with a 5
0 end within 2 kb of bins.
The transcript with the closest 5
0 end was selected. For
enhancer marks the association was made to the most
differentially expressed gene within 50 kb. Microarray
expression data were integrated using refseq IDs.
Motif enrichment analysis
For each histone mark, the top 5000 increasing and de-
creasing bins were selected. Bins next to each other were
merged. The regions were scanned with motifs from
Jaspar, Transfac and Uniprobe with a score threshold of
80%. Fisher test was used to compare the number of
sequences with at least one hit and the number of
sequences with no hits between the two sets. Wilcox test
was used to compare the rank of total number of hits
between the two sets. Motifs with a p-value < 0.05 from
both tests were defined as significant.
DNA methylation
RRBS was performed as previously described [51]. To
analyze potential changes in promoter DNA methylation
during chondrogenesis we examined 26,003 distinct
TSSs annotated on the UCSC Genome Browser (derived
from the gh19 refFlat database). For each sample, we
assigned a methylation value to each TSS for which we
had at least 5 distinct CpGs with at least 5X coverage
each within −1,000 bp to +1,500 bp relative to the TSS.
The methylation value for each such TSS was taken to
be the median methylation value of all of the CpGs
within this region with at least 5X coverage, using at
least three of the four donors in each state.
Sequences and data access
All ChIP-Seq and RRBS data have been deposited in
public databases and can be accessed from the NIH
Roadmap Project on Epigenomics website: http://www.
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base under accession GSE19465.
Additional files
Additional file 1: Genes with up-regulated expression during
chondrogenic differentiation. Shown is the microarray expression data
for all four donors, with mean values for chondrogenic and mesenchymal
cells and the enrichment ratio as log2 transformed values.
Additional file 2: Genes with down-regulated expression during
chondrogenic differentiation. Shown is the microarray expression data
for all four donors, with mean values for chondrogenic and mesenchymal
cells and the enrichment ratio as log2 transformed values.
Additional file 3: Histone modification tracks of non-changed
control genes. ChIP-seq signal tracks for histone modifications in a
100 kb window around the TSS of non-expressed control gene PDX1.
Exon-intron structures and coding strand direction are depicted on top.
UCSC Genome Browser on Human Feb. 2009 (GRCh37/hg19) assembly.
(A)ChIP-seq signal tracks for histone modifications in a 100 kb window
around the TSS of highly expressed control gene HSP90B1.
Additional file 4: Correlation between changes in gene expression
and changes in promoter mark H3K4me3. (A) Genome-wide
association between changes in gene expression (>2-fold, p<0.05) and
changes in H3K4me3 (>2-fold in at least 3 out of 4 donors) during 7 days
of differentiation. (B) GO term analysis of all genes where H3K4me3
changed >2-fold in 3 out of 4 donors. A cluster analysis using DAVID was
performed, and one typical term per cluster is shown. (C) Counts of
genes in the different expression clusters for all dynamic H3K4me3
regions and the 500 regions which changed the most in H3K4me3 (up or
down) during one week of chondrogenesis. (D) GO term analysis for
genes within the top 500 regions which increased or decreased in
H3K4me3, but failed to reach a >2-fold expression change. DAVID
analysis was performed, and one typical term per cluster is shown.
Additional file 5: Correlation between presence or absence of gene
expression and change in promoter associated histone
modifications. (A) Correlation between changes in histone marks and
presence or absence of changes in gene expression. Shown is the
percentage of genes clustered according to gene expression within
groups characterized by single or combined significant changes in
histone modifications. Expression cluster: ↑: >2fold upregulated, ↓: >2fold
downregulated, ↔: <2fold changed. Numbers are mean values for all
four donors. (B) Table showing the total number of genes associated to
the indicated dynamic regions and expression clusters. Numbers are
mean values of all four donors.
Additional file 6: Analysis of genes within the Top 500 with
increased H3K4me3 which did not meet significance criteriae for
increased gene expression. (A) Categories of genes which failed to
reach the significance criteriae (>2-fold increase, p<0.05) for increased
gene expression. (B) Details of gene expression analysis [52] and
epigenetic profile (bottom) for SOX5 as an example of a chondrogenic
signature gene with <2-fold, but significantly changed mRNA expression.
(C) ChIP-seq signal tracks for histone modifications of the SOX5 gene.
Exon-intron structures and coding strand direction are depicted on top.
UCSC Genome Browser. (D) ChIP-seq signal tracks of KLHL5 as an
example for genes within the top 500 genes with increased H3K4me3
due to activation of an alternative promoter, without change in the level
of mRNA expression. (E) Example of wrong gene annotation. ChIP-seq
signal tracks for histone modifications and data for changes in gene
expression for RAB4B and MIA.
Additional file 7: Correlation between gene expression and
changes in regulatory histone marks. (A) Correlation between
changes in histone marks and presence or absence of changes in gene
expression. Shown is the percentage of genes clustered according to
gene expression within groups characterized by single cis-regulatory
histone marks, Expression cluster: ↑: >2fold upregulated, ↓: >2fold
downregulated, ↔: <2fold changed. (B) Statistics of correlation between
changes in histone marks and gene expression. Shown is the percentage
of genes in different expression clusters associated to the indicated
>2fold changed histone modifications and their indicated combination.
Table showing the total number of genes associated to the indicated
dynamic regions and expression clusters. Numbers are mean values of all
four donors.
Additional file 8: Genes which have a change in expression
combined with a change in the level of H3K4me1 with in 50 kb of
the TSS. Shown is gene identification and localization with expression
values followed by the values for H3K4me1 marking where this is
significantly changed in nearby 500 bp bins. In addition the gene
expression for the associated genes is given as mean values for the three
investigated donors.
Additional file 9: Genes which have a change in expression
combined with a change in the level of H3K27Ac with in 50 kb of
the TSS. Shown is gene identification and localization with expression
values followed by the values for H3K27Ac marking where this is
significantly changed in nearby 500 bp bins. In addition the gene
expression for the associated genes is given as mean values for the three
investigated donors.
Additional file 10: DNA-Methylation levels during chondrogenesis.
(A) Distribution of methylation levels for individual CpGs with at least
10X coverage in each sample, as a function of local CpG density (+/−
50 bp). Shown is data of one typical donor. (B) Comparison of the
average MSC and Chondro methylation value for 13,210 distinct
transcription start sites (TSSs) annotated on the UCSC Genome Browser.
Additional file 11: Primers used in real-time RT-PCR and antibodies
used in immunohistochemistry.
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